|
|
|
40
|
06417
|
ACCORD MITOMYCIN 5MG INJ (INP/AAL) MITOMYCIN
|
MITOMYCIN
|
ACCORD MITOMYCIN
|
5MG VIAL
|
BQ
|
203.06
|
203.06
|
INJECTION
|
0
|
VIAL
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AAL
|
A. A. LAQUIS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
11045
|
ACCORD PROPRANOLOL 80MG TAB (INP/AAL)
|
PROPRANOLOL
|
ACCORD PROPRANOLOL
|
56'S
|
A
|
13.40
|
0.24
|
TABLET
|
150
|
TAB
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AAL
|
A. A. LAQUIS LTD
|
B
|
2424
|
BETA ADRENERGIC BLOCKING AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
40
|
1601AL
|
ACCORD DIAZEPAM 2MG TAB (INP/AAL) DIAZEPAM
|
DIAZEPAM
|
ACCORD DIAZEPAM
|
30'S
|
A
|
2.34
|
0.08
|
TABLET
|
120
|
TAB
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AAL
|
A. A. LAQUIS LTD
|
|
282408
|
BENZODIAZEPINES (SEDATIVES)
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
1603AK
|
ACCORD DIAZEPAM 10MG TAB (INP/AAL) DIAZEPAM
|
DIAZEPAM
|
ACCORD DIAZEPAM
|
30'S
|
A
|
3.67
|
0.12
|
TABLET
|
60
|
TAB
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AAL
|
A. A. LAQUIS LTD
|
|
282408
|
BENZODIAZEPINES (SEDATIVES)
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
1611U
|
DOCETERE 20MG INJ (DRL/AAL) DOCETAXEL
|
DOCETAXEL
|
DOCETERE
|
1 DS SYRNG
|
C
|
39.96
|
39.96
|
INJECTION
|
0
|
PFS
|
DRL
|
DR. REDDY'S LABORATORIES LTD
|
AAL
|
A. A. LAQUIS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
19536
|
IBANDRONIC ACID 1MG/ML INJ (INP/AAL)
|
IBANDRONIC ACID
|
IBANDRONIC ACID
|
6ML VIAL
|
C
|
9.51
|
9.51
|
INJECTION
|
0
|
VIAL
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AAL
|
A. A. LAQUIS LTD
|
|
9224
|
BONE RESORPTION INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
40
|
3592D
|
LAMEZ 50MG TAB (INP/AAL) LAMOTRIGINE
|
LAMOTRIGINE
|
LAMEZ
|
56'S
|
B
|
58.28
|
1.04
|
TABLET
|
0
|
TAB
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AAL
|
A. A. LAQUIS LTD
|
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
3631AX
|
ACCORD METOCLOPRAMIDE 10MG TAB (INP/AAL) METO
|
METOCLOPRAMIDE
|
ACCORD METOCLOPRAMIDE
|
30'S
|
A
|
1.96
|
0.07
|
TABLET
|
90
|
TAB
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AAL
|
A. A. LAQUIS LTD
|
|
5632
|
GI PROKINETIC AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
GASTROINTESTINAL DRUGS
|
|
|
|
|
40
|
3701BE
|
SELECT FLEX PLUS GLUC (JOH/AAL) DIAGNOSTIC B
|
DIAGNOSTIC BLOOD GLUCOSE
|
SELECT FLEX PLUS
|
50'S
|
A
|
39.42
|
39.42
|
GLUCOSE STRI
|
1
|
PACK
|
JOH
|
JOHNSON & JOHNSON (T'DAD) LTD.
|
AAL
|
A. A. LAQUIS LTD
|
B
|
3626
|
DIABETES MELLITUS
|
2022-04-01
|
2024-03-31
|
|
|
6
|
DIAGNOSTIC AGENTS
|
|
|
|
|
41
|
3701BE
|
SELECT FLEX PLUS GLUC (JOH) DIAGNO
|
DIAGNOSTIC BLOOD GLUCOSE
|
SELECT FLEX PLUS
|
50'S
|
A
|
39.23
|
39.2254
|
PACK
|
1
|
BOX
|
JOH
|
JOHNSON & JOHNSON (T'DAD) LTD.
|
AAL
|
A. A. LAQUIS LTD
|
B
|
3626
|
DIABETES MELLITUS
|
2024-04-01
|
2026-03-31
|
|
|
6
|
DIABETES MELLITUS
|
|
|
|
|
42
|
3701BE
|
SELECT FLEX PLUS GLUC (JOH) DIAGNO
|
DIAGNOSTIC BLOOD GLUCOSE
|
SELECT FLEX PLUS
|
50'S
|
A
|
40.39
|
40.39
|
PACK
|
1
|
BOX
|
JOH
|
JOHNSON & JOHNSON (T'DAD) LTD.
|
AAL
|
A. A. LAQUIS LTD
|
B
|
3626
|
DIABETES MELLITUS
|
2026-04-01
|
2028-03-31
|
|
|
6
|
DIABETES MELLITUS
|
|
|
|
|
40
|
3701V
|
LIFESCAN ONE TOUCH ULTRA GLUC (JOH/AAL) DIAG
|
DIAGNOSTIC BLOOD GLUCOSE
|
LIFESCAN ONE TOUCH ULTRA
|
50'S
|
A
|
39.42
|
39.42
|
GLUCOSE STRI
|
1
|
PACK
|
JOH
|
JOHNSON & JOHNSON (T'DAD) LTD.
|
AAL
|
A. A. LAQUIS LTD
|
B
|
3626
|
DIABETES MELLITUS
|
2022-04-01
|
2024-03-31
|
|
|
6
|
DIAGNOSTIC AGENTS
|
|
|
|
|
40
|
4181BA
|
REDITUX 10MG/ML INJ (DRL/AAL) RITUXIMAB
|
RITUXIMAB
|
REDITUX
|
50ML
|
C
|
383.56
|
383.56
|
INJECTION
|
0
|
VIAL
|
DRL
|
DR. REDDY'S LABORATORIES LTD
|
AAL
|
A. A. LAQUIS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
4841F
|
ZOPICON 7.5MG TAB (INP/AAL) ZOPICLONE
|
ZOPICLONE
|
ZOPICON
|
100'S
|
A
|
19.03
|
0.19
|
TABLET
|
30
|
TAB
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AAL
|
A. A. LAQUIS LTD
|
|
282492
|
ANXIOLYTICS, SEDATIVES AND HYPNOTICS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
42
|
4941A
|
ALBUMIN 20% INJ (INP)
|
ALBUMIN
|
ALBUMIN
|
50ML VIAL
|
BQ
|
277.27
|
277.27
|
VIAL
|
40
|
VIAL
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AAL
|
A. A. LAQUIS LTD
|
|
8004
|
SERUMS
|
2026-04-01
|
|
|
IV
|
0
|
SERUMS
|
|
|
|
|
40
|
65715
|
SKIZORIL 25MG TAB (INP/AAL) CLOZAPINE
|
CLOZAPINE
|
SKIZORIL
|
500'S
|
BP
|
92.45
|
0.18
|
TABLET
|
0
|
TAB
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AAL
|
A. A. LAQUIS LTD
|
|
28160804
|
ATYPICAL ANTIPSYCHOTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
71318
|
ACCORD REPAGLINIDE 0.5MG TAB (INP/AAL) REPAGL
|
REPAGLINIDE
|
ACCORD REPAGLINIDE
|
30'S
|
C
|
58.36
|
1.95
|
TABLET
|
0
|
TAB
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AAL
|
A. A. LAQUIS LTD
|
|
682016
|
MEGLITINIDES
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
40
|
71328
|
ACCORD REPAGLINIDE 1MG TAB (INP/AAL) REPAGLIN
|
REPAGLINIDE
|
ACCORD REPAGLINIDE
|
30'S
|
C
|
87.56
|
2.92
|
TABLET
|
0
|
TAB
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AAL
|
A. A. LAQUIS LTD
|
|
682016
|
MEGLITINIDES
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
40
|
7284D
|
TOPAZ 50MG TAB (INP/AAL) TOPIRAMATE
|
TOPIRAMATE
|
TOPAZ
|
60'S
|
BP
|
9.51
|
0.16
|
TABLET
|
0
|
TAB
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AAL
|
A. A. LAQUIS LTD
|
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
7581M
|
ACCORD PIOGLITAZONE 15MG TAB (INP/AAL) PIOGLI
|
PIOGLITAZONE
|
ACCORD PIOGLITAZONE
|
28'S
|
C
|
25.53
|
0.91
|
TABLET
|
0
|
TAB
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AAL
|
A. A. LAQUIS LTD
|
|
682028
|
THIAZOLIDINEDIONES
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
